AU2890899A - Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists - Google Patents
Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonistsInfo
- Publication number
- AU2890899A AU2890899A AU28908/99A AU2890899A AU2890899A AU 2890899 A AU2890899 A AU 2890899A AU 28908/99 A AU28908/99 A AU 28908/99A AU 2890899 A AU2890899 A AU 2890899A AU 2890899 A AU2890899 A AU 2890899A
- Authority
- AU
- Australia
- Prior art keywords
- prophylaxis
- treatment
- receptor antagonists
- migraine headaches
- synthetase inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000019695 Migraine disease Diseases 0.000 title 1
- 206010027603 Migraine headaches Diseases 0.000 title 1
- 108010069102 Thromboxane-A synthase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7800198P | 1998-03-13 | 1998-03-13 | |
| US60078001 | 1998-03-13 | ||
| PCT/US1999/004650 WO1999045905A2 (en) | 1998-03-13 | 1999-03-11 | Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2890899A true AU2890899A (en) | 1999-09-27 |
Family
ID=22141292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28908/99A Abandoned AU2890899A (en) | 1998-03-13 | 1999-03-11 | Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2890899A (en) |
| WO (1) | WO1999045905A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| AU2001264729A1 (en) * | 2000-05-22 | 2001-12-03 | Nitromed, Inc. | Thromboxane inhibitors, compositions and methods of use related applications |
| MXPA05006954A (en) | 2002-12-26 | 2005-09-22 | Pozen Inc | Multilayer Dosage Forms Containing NSAIDs and Triptans. |
| AU2004264722A1 (en) * | 2003-08-07 | 2005-02-24 | B.M.R.A. Corporation B.V. | Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxigenase-1 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK471479A (en) * | 1978-12-13 | 1980-06-14 | Pfizer | PROCEDURE FOR PREPARING IMIDAZOLD DERIVATIVES AND SALTS THEREOF |
| IL97144A (en) * | 1990-02-27 | 1994-11-28 | Erba Carlo Spa | Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives, their preparation and pharmaceutical compositions containing them |
| DE4024345A1 (en) * | 1990-07-27 | 1992-01-30 | Schering Ag | CYCLOPENTE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL USE |
| WO1992019182A2 (en) * | 1991-04-24 | 1992-11-12 | Board Of Regents, The University Of Texas System | Method of attenuation of neointimal proliferation |
| DE4114330A1 (en) * | 1991-05-02 | 1992-11-05 | Basf Ag | NEW COMBINATION OF MEDICINAL PRODUCTS |
| US5605917A (en) * | 1994-12-22 | 1997-02-25 | Bristol-Myers Squibb Company | Method of treating dysmenorrhea employing an interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analog |
-
1999
- 1999-03-11 AU AU28908/99A patent/AU2890899A/en not_active Abandoned
- 1999-03-11 WO PCT/US1999/004650 patent/WO1999045905A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999045905A3 (en) | 1999-10-21 |
| WO1999045905A2 (en) | 1999-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0600103A2 (en) | Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders | |
| HU0101158D0 (en) | Use of glycogen phosphorylase inhibitors | |
| AU2002340010A1 (en) | Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors | |
| AU3109099A (en) | Allosteric inhibitors and activators of pyruvate kinase | |
| IL141957A0 (en) | 5ht1 receptor agonists and metoclopramide for the treatment of migraine | |
| NO20005255L (en) | Pyrazole pyrimidine CGMPPDE5 inhibitors for the treatment of sexual dysfunction | |
| AU6340600A (en) | Telomerase inhibitors and methods of their use | |
| AU2001272852A1 (en) | Composition for the treatment of migraine | |
| AU2002219002A1 (en) | Method and device for treating the surfaces of items | |
| SI0736525T1 (en) | Benzonitriles as 5-HT agonists and antagonists | |
| AU2002256085A1 (en) | Quinoline inhibitors of hyak1 and hyak3 kinases | |
| AU2190400A (en) | Inhibitors of beta-lactamases and uses therefor | |
| AU2002232400A1 (en) | Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis | |
| EP1385872A4 (en) | Inhibitors of receptor activator of nf-kappa b and uses thereof | |
| AU2001257032A1 (en) | Cloning, overexpression and therapeutic uses of bioactive histidine ammonia lyase | |
| AU2890899A (en) | Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists | |
| AU2876000A (en) | Tyrosine kinase inhibitors and methods of using the same | |
| HU0001888D0 (en) | 5ht1 receptor agonists and either cox-2 inhibitor or nsaid for the treatment of migraine | |
| AU2002342715A1 (en) | Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors | |
| AU2002306845A1 (en) | Telomerase inhibitors and methods of their use | |
| AU2233095A (en) | Cloning and expression of human gmp synthetase, its use in screening for inhibitors of human gmp synthetase and inhibitors of human gmp synthetase | |
| AU2002339673A1 (en) | Agonists and antagonists of ryzn for the treatment of metabolic disorders | |
| AU2002232457A1 (en) | Method of treating and preventing migraine headaches | |
| AU4021700A (en) | Methods of use of beta1-integrin inhibitors | |
| AU1375699A (en) | Preemptive prophylaxis of migraine device and method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |